Apyx Medical Corporation
APYX
$3.63
-$0.06-1.63%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.86% | -1.32% | -5.14% | -6.27% | -8.11% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.86% | -1.32% | -5.14% | -6.27% | -8.11% |
| Cost of Revenue | 5.65% | -6.89% | -4.47% | -0.57% | 0.82% |
| Gross Profit | 12.55% | 2.33% | -5.55% | -9.52% | -13.03% |
| SG&A Expenses | -16.25% | -21.01% | -21.58% | -16.11% | -10.66% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.44% | -18.12% | -17.86% | -12.38% | -7.40% |
| Operating Income | 65.79% | 55.94% | 45.48% | 27.08% | 5.54% |
| Income Before Tax | 53.51% | 49.57% | 40.40% | 13.58% | -9.52% |
| Income Tax Expenses | 7.14% | 6.00% | 292.97% | 321.43% | 110.36% |
| Earnings from Continuing Operations | 52.86% | 49.08% | 39.27% | 12.08% | -24.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -210.42% | -119.51% | -68.22% | 1.96% | -29.93% |
| Net Income | 52.22% | 48.88% | 39.16% | 12.14% | -25.38% |
| EBIT | 65.79% | 55.94% | 45.48% | 27.08% | 5.54% |
| EBITDA | 68.26% | 57.41% | 46.40% | 27.61% | 5.26% |
| EPS Basic | 58.75% | 55.60% | 44.85% | 16.76% | -23.04% |
| Normalized Basic EPS | 58.98% | 50.51% | 39.27% | 16.85% | -9.89% |
| EPS Diluted | 58.75% | 55.60% | 44.85% | 16.76% | -23.04% |
| Normalized Diluted EPS | 58.98% | 50.51% | 39.27% | 16.85% | -9.89% |
| Average Basic Shares Outstanding | 15.63% | 15.76% | 11.36% | 7.00% | 2.64% |
| Average Diluted Shares Outstanding | 15.63% | 15.76% | 11.36% | 7.00% | 2.64% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |